| Ytd | 61.63% | |
| 1y | 201.26% |
| Open | 166.44 | Prev Close | 167.21 | Low | 163.50 | High | 168.90 | Mkt Cap | 22.15B |
| Vol | 0.00 | Avg Vol | 2.68M | EPS | -2.58 | P/E | -63.99 | Forward P/E | -371.47 |
| Beta | 1.59 | Short Ratio | 3.28 | Inst. Own | 98.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 146.96 | 200-d Avg | 110.20 | 1yr Est | 194.29 |
GH News
Guardant Health is experiencing robust growth, driven by its MRD and screening businesses. Recent FD
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Empowered Funds LLC trimmed its holdings in Guardant Health, Inc. (NASDAQ: GH) by 81.3% during the u
Dimensional Fund Advisors LP lowered its position in Guardant Health, Inc. (NASDAQ: GH) by 40.4% in
On August 06, 2026, Guardant Health Inc (GH) shares fell 3.4% today, trading at $157.58. Over the pa
Three of these watchlist stocks have already passed their earnings tests.
U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g
Analysts change outlook & price targets for Crocs, Monolithic Power, Axos Financial, Amazon, Kar
AngloGold Ashanti plc (âAngloGold Ashantiâ, âAGAâ, the âCompanyâ or the âGroupâ) sai
Guardant Health, Inc. (GH) Q2 2026 Earnings Call Transcript
Guardant Health (GH) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Es
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Guardant Health (GH), delve
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Caxton Associates LLP purchased a new position in shares of Guardant Health, Inc. (NASDAQ: GH) in th
VOOG focuses on mega-cap tech leaders while ISCG diversifies across smaller firms.
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely e
Amova Asset Management Americas Inc. trimmed its position in shares of Guardant Health, Inc. (NASDAQ
Guggenheim analyst Subbu Nambi maintains Guardant Health (NASDAQ:GH) with a Buy and raises the pr
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and raises
ISCG offers lower fees and broader diversification, while RZG's portfolio strategy has outperformed
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Wall Street analysts change ratings for top stocks: CRWD price target raised, FULC target lowered, H
Quantum computing, AI and semiconductor-linked stocks dominated last week's large-cap gainers as
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment fo
Discover last week's top 10 large-cap stock gainers, why they rallied, and what catalysts drove
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robins
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn